Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitol

Antiviral Therapy

Volumn 9, Issue 4, 2004, Pages 479-489

  Freyschmidt, Eva Jasmin ^a   Alonso, Angel ^a   Hartmann, Gunther ^b   Gissmann, Lutz ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; HYBRID PROTEIN; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; SORBITOL;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW CELL; CELL STIMULATION; CHIMERA; CPG ISLAND; DENDRITIC CELL; HIGH RISK PATIENT; IMMUNE RESPONSE; IMMUNOGENICITY; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS CAPSID; VIRUS PARTICLE; WART VIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD40; ANTIGENS, CD80; BONE MARROW; CAPSID PROTEINS; CELLS, CULTURED; CPG ISLANDS; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERCELLULAR ADHESION MOLECULE-1; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; SORBITOL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 4344614767     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Bosch FX, Lorincz A, Munoz N, Meijer CJ & Shah K. The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology 2002; 55:244-265.
2. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Reviews Cancer 2002; 2:342-350.
3. Parkin DM, Pisani P & Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. International Journal of Cancer 1999; 80:827-841.
4. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM & Jansen KU. A controlled trial of a human papillomavirus type 16 vaccine. New England Journal of Medicine 2002; 347:1645-1651.
5. Berry JM & Palefsky JM. A review of human papillomavirus vaccines: from basic science to clinical trials. Frontiers in Bioscience 2003; 8:S333-845.
6. Müller M, Zhou J, Reed TD, Rittmüller C, Burger A, Gabelsberger J, Braspenning J & Gissmann L. Chimeric papillomavirus-like particles. Virology 1997; 234:93-111.
7. Greenstone HL, Nieland JD, de Visser KE, De Bruijn ML, Kirnbauer R, Roden RB, Lowy DR, Kast WM & Schiller JT. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. Proceedings of the National Academy of Sciences, USA 1998; 95:1800-1805.
8. Jochmus I, Schäfer K, Faath S, Müller M & Gissmann L. Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine. Archives of Medical Research 1999; 30:269-274.
9. Schäfer K, Müller M, Faath S, Henn A, Osen W, Zentgraf H, A Benner, Gissmann L & Jochmus I. Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection. International Journal of Cancer 1999; 81:881-888.
10. Öhlschläger P, Osen W, Dell K, Faath S, Garcea RL, Jochmus I, Müller M, Pawlita M, Schäfer K, Sehr P, Staib C, Sutter G & Gissmann L. Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice. Journal of Virology 2003; 77:4635-4645.
11. Lenz P, Day PM, Pang YY, Frye SA, Jensen PN, Lowy DR, & Schiller JT. Papillomavirus-like particles induce acute activation of dendritic cells. Journal of Immunology 2001; 166:5346-5355.
12. Rudolf MP, Fausch SC, Da Silva DM & Kast WM. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro. Journal of Immunology 2001; 166:5917-5924.
13. Wagner H. Toll meets bacterial CpG-DNA. Immunity 2001; 14:499-502.
14. Hartmann G, Weeratna RD, Ballas ZK, Payette P, Blackwell S, Suparto I, Rasmussen L, Waldschmidt M, Sajuthi D, Purcell RH, Davis HL & Krieg AM. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. Journal of Immunology 2000; 164:1617-1624.
15. Lipford GB, Bendigs S, Heeg K & Wagner H. Poly-guanosine motifs costimulate antigen-reactive CD8 T cells while bacterial CpG-DNA affect T-cell activation via antigen-presenting cell-derived cytokines. Immunology 2000; 101:46-52.
16. Jakob T, Walker PS, Krieg AM, Udey MC & Vogel JC. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. Journal of Immunology 1998; 161:3042-3049.
17. Sparwasser T, Koch ES, Vabulas RM, Heeg K, Lipford GB, Ellwart JW & Wagner H. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. European Journal of Immunology 1998; 28:2045-2054.
18. Hartmann G, Weiner GJ & Krieg AM. CpG DNA: a potent signal for growth, activation, and maturation of uman dendritic cells. Proceedings of the National Academy of Sciences, USA 1999; 96:9305-9310.
19. Heckelsmiller K, Rall K, Beck S, Schlamp A, Seiderer J, Jahrsdorfer B, Krug A, Rothenfusser S, Endres S & Hartmann G. Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model. Journal of Immunology 2002; 169:3892-3899.
20. Junger WG, Hoyt DB, Hamreus M, Liu FC, Herdon-Remelius C, Junger W & Altman A. Hypertonic saline activates protein tyrosine kinases and mitogen-activated protein kinase p38 in T-cells. Journal of Trauma 1997; 42:437-443.
21. Rincon M, Enslen H, Raingeaud J, Recht M, Zapton T, Su MS, Penix LA, Davis RJ & Flavell RA. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO Journal 1998; 17:2817-2829.
22. Cheng HJ, Kartenbeck, Kabsch K, Mao X, Marques M & Alonso A. Stress kinase p38 mediates EGFR transactivation by hyperosmolar concentrations of sorbitol. Journal of Cellular Physiology 2002; 192:234-243.
23. Rodriguez I, Kaszkin M, Holloschi A, Kabsch K, Marques MM, Mao X & Alonso A. Hyperosmotic stress induces phosphorylation of cytosolic phospholipase A(2) in HaCaT cells by an epidermal growth factor receptor-mediated process. Cell Signal 2002; 14:839-848.
24. Lo HH, Teichmann P, Furstenberger G, Gimenez-Conti I & Fischer SM. Suppression or elevation of cytosolic phospholipase A2 alters keratinocyte prostaglandin synthesis, growth, and apoptosis. Cancer Research 1998; 58:4624-4631.
25. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N & Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. Journal of Immunological Methods 1999; 223:77-92.
26. Yi AK & Krieg AM. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel. Journal of Immunology 1998; 160:1240-1245.
27. Jiang HR, Muckersie E, Robertson M, Xu H, Liversidge J & Forrester JV. Secretion of interleukin-10 or interleukin-12 by LPS-activated dendritic cells is critically dependent on time of stimulus relative to initiation of purified DC culture. Journal of Leukocyte Biology 2002; 72:978-985.
28. Takeuchi O, Floshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K & Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11:443-451.
29. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K & Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. Journal of Immunology 1999; 162:3749-3752.
30. Weiner GJ, Liu HM, Wooldridge JE, Dahle CE & Krieg AM. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proceedings of the National Academy of Sciences, USA 1997; 94:10833-10837.
31. Feltkamp MC, Smits HL, Vierboom MP, Minnaar RP, de Jongh BM, Drijfhout JW, ter Schegget J, Melief J & Kast WM. Vaccination with cytotoxic T Iymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. European Journal of Immunology 1993; 23:2242-2249.
32. Tartakoff A, Vassalli P & Detraz M. Comparative studies of intracellular transport of secretory proteins. Journal of Cellular Biology 1978; 79:694-707.
33. Michel N, Öhlschläger P, Osen W, Freyschmidt EJ, Guthöhrlein H, Kaufmann AM, Müller M & Gissmann L. T cell response to human papillomavirus 16 E7 in mice: comparison of Cr release assay, intracellular IFN-gamma production, ELISPOT and tetramer staining. Intervirology 2002; 45:290-299.
34. Gissmann L, Osen W, Muller M & Jochmus I. Therapeutic vaccines for human papillomaviruses. Intervirology 2001; 44:167-167.
35. Navabi H, Jasani B, Adams M, Evans AS, Mason M, Crosby T & Borysiewicz L. Generation of in vitro autologous human cytotoxic T-cell response to E7 and HER-2/neu oncogene products using ex-vivo peptide loaded dendritic cells. Advances in Experimental Medicine & Biology 1997; 417:583-589.
36. De Bruijn ML, Schuurhuis DH, Vierboom MP, Vermeulen H, de Cock KA, Ooms ME, Ressing ME, Toebes M, Franken KL, Drijfhout JW, Ottenhoff TH, Offringa R & Melief CJ. Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells. Cancer Research 1998; 58:724-731.
37. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ & Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. Journal of Biological Chemistry 1995; 270:7420-7426.
38. Sato Y, Yamakose H & Suzuki Y. Participation of band 3 protein in hypotonic hemolysis of human erythrocytes. Biological & Pharmaceutical Bulletin 1993; 16:188.
39. Khaware RK, Koul A & Prasad R. High membrane fluidity is related to NaCl stress in Candida membranefaciens. Biochemistry & Molecular Biology International 1995; 35:875-880.
40. Johannes C, Boes R & Obe G. Uptake of the restriction endonuclease Alul by Chinese hamster ovary cells measured by frequencies of induced chromosomal aberrations: effect of hypertonic concentrations of glycerol and sorbitol. Mutagenesis 1992; 7:225-232.
41. Chow JC, Young DW, Golenbock DT, Christ WJ & Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. Journal of Biological Chemistry 1999; 274:10689-10692.
42. Santin AD, Hermonat PL, Ravaggi A, Chiriva-Internati M, Zhan D, Pecorelli S, Parham GP & Cannon MJ. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer. Journal of Virology 1999; 73:5402-5410.
43. Rothenfusser S, Tuma E, Endres S & Hartmann G. Plasmacytoid dendritic cells: the key to CpG. Human Immunology 2002; 63:1111-1119.
44. Coley. http://www.coleypharma.com/coley/vaximmune